Vericel (VCEL) Cash from Financing Activities (2010 - 2026)

Vericel's (VCEL) quarterly Cash from Financing Activities came in at -$3.0 million in Q1 2026, down 193.15% year-on-year from $3.2 million in Q1 2025, and down 379.72% quarter-over-quarter from $1.1 million in Q4 2025.

Vericel (VCEL) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Vericel has disclosed Cash from Financing Activities across 17 years of filings, most recently posting -$3.0 million for Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at -$3.0 million, down 193.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $893000.0 (down 95.56% YoY), and the FY2025 annual result was $7.1 million, down 62.89% from the prior year.
  • Cash from Financing Activities came in at -$3.0 million for Q1 2026 at Vericel, down from $1.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $7.1 million in Q4 2024 to a low of -$3.0 million in Q1 2026.
  • The 5-year median for Cash from Financing Activities is $1.2 million (2025), against an average of $1.6 million.
  • Across the five-year window, Cash from Financing Activities surged 1886.92% in 2024 and sank 193.15% in 2026, its largest moves.
  • Vericel's Cash from Financing Activities stood at $605000.0 in 2022, then surged by 116.03% to $1.3 million in 2023, then surged by 443.84% to $7.1 million in 2024, then sank by 85.02% to $1.1 million in 2025, then tumbled by 379.72% to -$3.0 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$3.0 million (Q1 2026), $1.1 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Vericel 2.04 Bn 1.90 Bn 49.27 Mn -2.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.98 Mn
Mar 31, 2026 -2.98 Mn
Dec 31, 2025 1.07 Mn
Dec 31, 2025 1.07 Mn
Sep 30, 2025 1.17 Mn
Sep 30, 2025 1.17 Mn
Jun 30, 2025 1.64 Mn
Jun 30, 2025 1.64 Mn
Mar 31, 2025 3.20 Mn
Mar 31, 2025 3.20 Mn
Dec 31, 2024 7.11 Mn
Dec 31, 2024 7.11 Mn
Sep 30, 2024 5.52 Mn
Sep 30, 2024 5.52 Mn
Jun 30, 2024 4.30 Mn
Jun 30, 2024 4.30 Mn
Mar 31, 2024 2.13 Mn
Mar 31, 2024 2.13 Mn
Dec 31, 2023 1.31 Mn
Dec 31, 2023 1.31 Mn